pharmaceutical investing Ultragenyx, Kyowa Kirin Announce FDA Acceptance for Supplemental Biologics License
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer